Digital Content 
NEWS #PharmaBuzz
23 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/23/3171872/0/en/TRIDENT-a-dedicated-stroke-outcomes-trial-in-patients-with-a-history-of-intracerebral-hemorrhage-ICH-demonstrates-the-potential-advantages-of-intensive-blood-pressure-treatment-wit.html
29 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/piramal-pharma-solutions-supports-george-medicines-in-developing-its-new-drug-for-hypertension-widaplik-telmisartan-amlodipine-and-indapamide-302541305.html
21 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/21/3118577/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Azurity-Pharmaceuticals-to-commercialize-WIDAPLIK-telmisartan-amlodipine-and-indapamide-tablets-in-the-US.html
16 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250616203834/en/Veristat-Congratulates-George-Medicines-on-FDA-Approval-of-WIDAPLIK
09 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/09/3095734/0/en/George-Medicines-announces-FDA-approval-of-WIDAPLIK-telmisartan-amlodipine-and-indapamide-a-new-single-pill-combination-treatment-for-hypertension-in-adults-including-initial-treat.html
17 Jan 2020
// Leroy Leo LIVE MINT
https://www.livemint.com/companies/news/49-medicine-samples-fail-regulator-s-quality-tests-11579109764637.html
Share 